On September 15, CAR-T cell company Legend Biotech announced that the board of directors has appointed Zhang Ying as CEO, effective September 15, 2026. Prior to joining Legendary Biotech, Zhang Ying was the Chief Commercial Officer of Novartis International Business. During her tenure at Novartis, she also served as President of Novartis Innovative Pharmaceuticals China and President of Novartis China.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.